Graham Leese

15.7k total citations · 2 hit papers
209 papers, 10.2k citations indexed

About

Graham Leese is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology and Surgery. According to data from OpenAlex, Graham Leese has authored 209 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Endocrinology, Diabetes and Metabolism, 39 papers in Ophthalmology and 33 papers in Surgery. Recurrent topics in Graham Leese's work include Retinal Diseases and Treatments (38 papers), Retinal Imaging and Analysis (33 papers) and Diabetic Foot Ulcer Assessment and Management (33 papers). Graham Leese is often cited by papers focused on Retinal Diseases and Treatments (38 papers), Retinal Imaging and Analysis (33 papers) and Diabetic Foot Ulcer Assessment and Management (33 papers). Graham Leese collaborates with scholars based in United Kingdom, United States and Australia. Graham Leese's co-authors include Peter T. Donnan, Andrew D. Morris, Sarah H. Wild, Roland Jung, Robert S. Lindsay, Sam Philip, Helen M. Colhoun, Thenmalar Vadiveloo, Ning Yu and John McKnight and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Graham Leese

205 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

2004 939 citations Graham Leese et al. profile →
Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

2015 418 citations Robert S. Lindsay, Sarah H. Wild et al. profile →

Peers

Countries citing papers authored by Graham Leese

Since Specialization

Citations

This map shows the geographic impact of Graham Leese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Leese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Leese more than expected).

Fields of papers citing papers by Graham Leese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Leese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Leese. The network helps show where Graham Leese may publish in the future.

Co-authorship network of co-authors of Graham Leese

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Leese. A scholar is included among the top collaborators of Graham Leese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Leese. Graham Leese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Enrique Soto‐Pedre, Paul Newey, Graham Leese	19
2	Cohort profile: the Scottish Diabetes Research Network national diabetes cohort – a population-based cohort of people with diabetes in Scotland 2022 ·BMJ Open ·Stuart J. McGurnaghan, Luke A. K. Blackbourn, Thomas M. Caparrotta, Joseph Mellor, Anna Barnett, (unknown), Naveed Sattar, John McKnight, John R. Petrie, Sam Philip, Robert S. Lindsay, (unknown), David McAllister, Graham Leese, Ewan R. Pearson, Sarah H. Wild, Paul McKeigue, Helen M. Colhoun	15
3	Adherence to General Diabetes and Foot Care Processes, with Prompt Referral, Are Associated with Amputation-Free Survival in People with Type 2 Diabetes and Foot Ulcers: A Scottish National Registry Analysis 2022 ·Journal of Diabetes Research ·(unknown), Scott Cunningham, Christian Heiß, Mark Joy, Michael Feher, Graham Leese, Simon de Lusignan, Fabrizio Carinci	6
4	Thyrotoxicosis and hyperthyroidism: causes, diagnosis and management 2021 ·Pharmaceutical journal/The pharmaceutical journal ·Onyebuchi Okosieme, Jackie Gilbert, Kristien Boelaert, Colin Dayan, Mark Gurnell, Graham Leese, Christopher J. McCabe, Petros Perros, Vicki E. Smith, Graham R. Williams, Mark Vanderpump, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
5	The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes 2021 ·Diabetologia ·Andreas Höhn, Anita Jeyam, Thomas M. Caparrotta, Stuart J. McGurnaghan, Joseph O’Reilly, Luke A. K. Blackbourn, Rory J. McCrimmon, Graham Leese, John McKnight, Brian Kennon, Robert S. Lindsay, Naveed Sattar, Sarah H. Wild, Paul McKeigue, Helen M. Colhoun	5
6	Development and validation of a clinical prediction rule for development of diabetic foot ulceration: an analysis of data from five cohort studies 2021 ·BMJ Open Diabetes Research & Care ·Francesca M. Chappell, Fay Crawford, Margaret Horne, Graham Leese, Angela Martin, David Weller, Andrew J.M. Boulton, Caroline A. Abbott, Matilde Monteiro‐Soares, Aristidis Veves, Richard D Riley	10
7	Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study 2021 ·Diabetes Care ·Joseph O’Reilly, Anita Jeyam, Thomas M. Caparrotta, Joseph Mellor, Andreas Höhn, Paul McKeigue, (unknown), Luke A. K. Blackbourn, Rory J. McCrimmon, Sarah H. Wild, John R. Petrie, John McKnight, Brian Kennon, John Chalmers, (unknown), Graham Leese, Robert S. Lindsay, Naveed Sattar, Fraser W. Gibb, Helen M. Colhoun	16
8	Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study 2021 ·Diabetologia ·Anita Jeyam, Fraser W. Gibb, John McKnight, Joseph O’Reilly, Thomas M. Caparrotta, Andreas Höhn, Stuart J. McGurnaghan, Luke A. K. Blackbourn, Sara Hatam, Brian Kennon, Rory J. McCrimmon, Graham Leese, Sam Philip, Naveed Sattar, Paul McKeigue, Helen M. Colhoun	19
9	Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model 2020 ·Health Technology Assessment ·Fay Crawford, Francesca M. Chappell, James Lewsey, Richard D Riley, Neil Hawkins, Donald Nicolson, Robert Heggie, Marie Smith, Margaret Horne, (unknown), Angela Martin, Saket Gupta, Karen Gray, David Weller, Julie Brittenden, Graham Leese	17
10	Complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data 2020 ·Diabetic Medicine ·Robert Heggie, Francesca M. Chappell, Fay Crawford, Angela Martin, Saket Gupta, Neil Hawkins, Margaret Horne, Graham Leese, Jim Lewsey	6
11	The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study 2019 ·Diabetologia ·Stuart J. McGurnaghan, Liam Brierley, Thomas M. Caparrotta, Paul McKeigue, Luke A. K. Blackbourn, Sarah H. Wild, Graham Leese, Rory J. McCrimmon, John McKnight, Ewan R. Pearson, John R. Petrie, Naveed Sattar, Helen M. Colhoun	30
12	Attitudes and perceptions of health professionals towards management of hypothyroidism in general practice: a qualitative interview study 2018 ·BMJ Open ·(unknown), Kathryn King, Onyebuchi Okosieme, Simon H. S. Pearce, (unknown), Peter Taylor, (unknown), Colin Dayan, Graham Leese, Salman Razvi, Scott Wilkes	24
13	LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease 2017 ·Trials ·David Preiss, Jane Armitage, James R. Olson, Graham Scotland, Graham Leese, Helen M. Colhoun, (unknown), Katie Murphy, Jennifer Logue	2
14	Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission 2017 ·Diabetes Care ·Sarah H. Wild, Jeremy Walker, Joanne R Morling, David McAllister, Helen M. Colhoun, Bassam Farran, Stuart J. McGurnaghan, Rory J. McCrimmon, Stephanie H. Read, Naveed Sattar, Christopher D. Byrne, Robert S. Lindsay, Graham Leese, John McKnight, John R. Petrie, John Chalmers, Colin Fischbacher, Scott Cunningham, Olívia Wu, Sam Philip	98
15	What predicts adverse outcomes in untreated primary hyperparathyroidism 2011 ·Ning Yu, Peter T. Donnan, Graham Leese	6
16	Do men develop type 2 diabetes at lower body mass indices than women? 2011 ·Diabetologia ·Jennifer Logue, Jeremy Walker, Helen M. Colhoun, Graham Leese, Robert S. Lindsay, John McKnight, Andrew D. Morris, D. Pearson, John R. Petrie, Sam Philip, Sarah H. Wild, Naveed Sattar	226
17	Is it safe for patients taking thyroxine to have a low but not suppressed serum TSH concentration 2010 ·Graham Leese, Robert E. Flynn	2
18	The Thyroid Epidemiology, Audit, and Research Study (TEARS): The Natural History of Endogenous Subclinical Hyperthyroidism 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Thenmalar Vadiveloo, Peter T. Donnan, Lynda Cochrane, Graham Leese	78
19	Twelve month changes in physical activity and quality of life outcomes following a physical activity consultation delivered in person or in written form in Type 2 diabetes : the TIME2ACT study 2009 ·Diabetes ·Alison Kirk, (unknown), Graham Leese, Nanette Mutrie	1
20	Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS) 2007 ·Clinical Endocrinology ·Graham Leese, (unknown), Roland Jung, Thomas M. MacDonald, Michael J. Murphy, Andrew D. Morris	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact